Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1989 Jul 1;261(1):311–312.

`Complementary peptides': a response

J Edwin Blalock *, Terry S Elton †, Suzanne Oparil
PMCID: PMC1138823

Full text

PDF
311

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blalock J. E., Bost K. L. Binding of peptides that are specified by complementary RNAs. Biochem J. 1986 Mar 15;234(3):679–683. doi: 10.1042/bj2340679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blalock J. E., Bost K. L. Ligand receptor characteristics of peptides encoded by complementary nucleic acids: implications for a molecular recognition code. Recent Prog Horm Res. 1988;44:199–222. doi: 10.1016/b978-0-12-571144-9.50011-9. [DOI] [PubMed] [Google Scholar]
  3. Blalock J. E., Smith E. M. Hydropathic anti-complementarity of amino acids based on the genetic code. Biochem Biophys Res Commun. 1984 May 31;121(1):203–207. doi: 10.1016/0006-291x(84)90707-1. [DOI] [PubMed] [Google Scholar]
  4. Bost K. L., Blalock J. E. Molecular characterization of a corticotropin (ACTH) receptor. Mol Cell Endocrinol. 1986 Jan;44(1):1–9. doi: 10.1016/0303-7207(86)90099-7. [DOI] [PubMed] [Google Scholar]
  5. Bost K. L., Smith E. M., Blalock J. E. Regions of complementarity between the messenger RNAs for epidermal growth factor, transferrin, interleukin-2 and their respective receptors. Biochem Biophys Res Commun. 1985 May 16;128(3):1373–1380. doi: 10.1016/0006-291x(85)91092-7. [DOI] [PubMed] [Google Scholar]
  6. Bost K. L., Smith E. M., Blalock J. E. Similarity between the corticotropin (ACTH) receptor and a peptide encoded by an RNA that is complementary to ACTH mRNA. Proc Natl Acad Sci U S A. 1985 Mar;82(5):1372–1375. doi: 10.1073/pnas.82.5.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brentani R. R., Ribeiro S. F., Potocnjak P., Pasqualini R., Lopes J. D., Nakaie C. R. Characterization of the cellular receptor for fibronectin through a hydropathic complementarity approach. Proc Natl Acad Sci U S A. 1988 Jan;85(2):364–367. doi: 10.1073/pnas.85.2.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carr D. J., Blalock J. E., Bost K. L. Monoclonal antibody against a peptide specified by [Met]-enkephalin complementary RNA recognizes the delta-class opioid receptor. Immunol Lett. 1989 Feb;20(3):181–186. doi: 10.1016/0165-2478(89)90077-1. [DOI] [PubMed] [Google Scholar]
  9. Carr D. J., Bost K. L., Blalock J. E. An antibody to a peptide specified by an RNA that is complementary to gamma-endorphin mRNA recognizes an opiate receptor. J Neuroimmunol. 1986 Oct;12(4):329–337. doi: 10.1016/0165-5728(86)90039-1. [DOI] [PubMed] [Google Scholar]
  10. Carr D. J., Bost K. L., Blalock J. E. The production of antibodies which recognize opiate receptors on murine leukocytes. Life Sci. 1988;42(25):2615–2624. doi: 10.1016/0024-3205(88)90331-1. [DOI] [PubMed] [Google Scholar]
  11. Carr D. J., DeCosta B., Jacobson A. E., Bost K. L., Rice K. C., Blalock J. E. Immunoaffinity-purified opiate receptor specifically binds the delta-class opiate receptor ligand, cis-(+)-3-methylfentanylisothiocyanate, SUPERFIT. FEBS Lett. 1987 Nov 30;224(2):272–276. doi: 10.1016/0014-5793(87)80468-4. [DOI] [PubMed] [Google Scholar]
  12. Elton T. S., Dion L. D., Bost K. L., Oparil S., Blalock J. E. Purification of an angiotensin II binding protein by using antibodies to a peptide encoded by angiotensin II complementary RNA. Proc Natl Acad Sci U S A. 1988 Apr;85(8):2518–2522. doi: 10.1073/pnas.85.8.2518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guillemette G., Boulay G., Gagnon S., Bosse R., Escher E. The peptide encoded by angiotensin II complementary RNA does not interfere with angiotensin II action. Biochem J. 1989 Jul 1;261(1):309–309. doi: 10.1042/bj2610309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Görcs T. J., Gottschall P. E., Coy D. H., Arimura A. Possible recognition of the GnRH receptor by an antiserum against a peptide encoded by nucleotide sequence complementary to mRNA of a GnRH precursor peptide. Peptides. 1986 Nov-Dec;7(6):1137–1145. doi: 10.1016/0196-9781(86)90144-0. [DOI] [PubMed] [Google Scholar]
  15. Johnson H. M., Torres B. A. A novel arginine vasopressin-binding peptide that blocks arginine vasopressin modulation of immune function. J Immunol. 1988 Oct 1;141(7):2420–2423. [PubMed] [Google Scholar]
  16. Kang C. Y., Brunck T. K., Kieber-Emmons T., Blalock J. E., Kohler H. Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide. Science. 1988 May 20;240(4855):1034–1036. doi: 10.1126/science.3368787. [DOI] [PubMed] [Google Scholar]
  17. Knigge K. M., Piekut D. T., Berlove D. Immunocytochemistry of a vasopressin (AVP) receptor with anti-idiotype antibody: inhibition of staining with a peptide (PVA) encoded by an RNA that is complementary to AVP mRNA. Neurosci Lett. 1988 Apr 12;86(3):269–271. doi: 10.1016/0304-3940(88)90494-6. [DOI] [PubMed] [Google Scholar]
  18. Knutson V. P. Insulin-binding peptide. Design and characterization. J Biol Chem. 1988 Oct 5;263(28):14146–14151. [PubMed] [Google Scholar]
  19. Mulchahey J. J., Neill J. D., Dion L. D., Bost K. L., Blalock J. E. Antibodies to the binding site of the receptor for luteinizing hormone-releasing hormone (LHRH): generation with a synthetic decapeptide encoded by an RNA complementary to LHRH mRNA. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9714–9718. doi: 10.1073/pnas.83.24.9714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Reiher W. E., 3rd, Blalock J. E., Brunck T. K. Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2. Proc Natl Acad Sci U S A. 1986 Dec;83(23):9188–9192. doi: 10.1073/pnas.83.23.9188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shai Y., Flashner M., Chaiken I. M. Anti-sense peptide recognition of sense peptides: direct quantitative characterization with the ribonuclease S-peptide system using analytical high-performance affinity chromatography. Biochemistry. 1987 Feb 10;26(3):669–675. doi: 10.1021/bi00377a002. [DOI] [PubMed] [Google Scholar]
  22. Smith L. R., Bost K. L., Blalock J. E. Generation of idiotypic and anti-idiotypic antibodies by immunization with peptides encoded by complementary RNA: a possible molecular basis for the network theory. J Immunol. 1987 Jan 1;138(1):7–9. [PubMed] [Google Scholar]
  23. Soffer R. L., Bandyopadhyay S., Rosenberg E., Hoeprich P., Teitelbaum A., Brunck T., Colby C. B., Gloff C. Unexpected binding of an octapeptide to the angiotensin II receptor. Proc Natl Acad Sci U S A. 1987 Dec;84(24):9219–9222. doi: 10.1073/pnas.84.24.9219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Weigent D. A., Hoeprich P. D., Bost K. L., Brunck T. K., Reiher W. E., 3rd, Blalock J. E. The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 that binds to the interleukin-2 receptor. Biochem Biophys Res Commun. 1986 Aug 29;139(1):367–374. doi: 10.1016/s0006-291x(86)80123-1. [DOI] [PubMed] [Google Scholar]
  25. Whitaker J. N., Sparks B. E., Walker D. P., Goodin R., Benveniste E. N. Monoclonal idiotypic and anti-idiotypic antibodies produced by immunization with peptides specified by a region of human myelin basic protein mRNA and its complement. J Neuroimmunol. 1989 Apr;22(2):157–166. doi: 10.1016/0165-5728(89)90047-7. [DOI] [PubMed] [Google Scholar]
  26. de Gasparo M., Whitebread S., Einsle K., Heusser C. Are the antibodies to a peptide complementary to angiotensin II useful to isolate the angiotensin II receptor? Biochem J. 1989 Jul 1;261(1):310–311. doi: 10.1042/bj2610310. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES